Vetoquinol SA (LON:0O1O)
76.90
0.00 (0.00%)
At close: Apr 23, 2025
Vetoquinol Revenue
In the year 2024, Vetoquinol had annual revenue of 539.20M EUR with 1.88% growth. Vetoquinol had revenue of 274.76M in the half year ending December 31, 2024, with 2.14% growth.
Revenue
539.20M EUR
Revenue Growth
+1.88%
P/S Ratio
1.74
Revenue / Employee
220.98K EUR
Employees
2,440
Market Cap
777.72M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 539.20M | 9.93M | 1.88% |
Dec 31, 2023 | 529.27M | -10.51M | -1.95% |
Dec 31, 2022 | 539.78M | 18.51M | 3.55% |
Dec 31, 2021 | 521.27M | 93.81M | 21.94% |
Dec 31, 2020 | 427.47M | 31.48M | 7.95% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Oxford Nanopore Technologies | 183.19M |